YJYue Jiang

Yue Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yue Jiang has a total of 135 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A multimethod assessment of the vascular surgery program director experience in creating effective training environments

    by Margaret A. Reilly, Christina L. Cui, Yue Jiang, Eric B. Pillado, Ruojia Debbie Li, Joshua S. Eng, Leanne E. Grafmuller, Kathryn L. DiLosa, Palma M. Shaw, Yue-Yung Hu, et al.

  • Open Access

    Opioid use after adult liver transplantation: Incidence, high-risk use, and adverse events in a large US cohort

    by Sarah R. Lieber, Olgert Bardhi, Yue Jiang, Alex R. Jones, Prajwal Gowda, Shannan R. Tujios, William Tirone, Madhukar S. Patel, Parsia Vagefi, Steven Hanish, et al.

    Background: Opioid use contributes to significant morbidity, posing specific risks to liver transplant recipients (LTRs). This study aimed to characterize outpatient opioid use before and after liver transplantation (LT) and identify risk factors for high-risk, incident, and chronic use and related complications. Methods: Adult LTRs were identified from 2006 to 2021 in IQVIA PharMetrics Plus for Academics, a claims database representative of the commercially insured US population. Opioid use was evaluated 30–365 days after LT; high-risk use was defined as >50 morphine milligram equivalents (MMEs) per day or concurrent opioid–benzodiazepine use. Factors associated with use, including high-risk use, were identified using multivariable logistic regression analysis. Landmark analyses assessed the association between outpatient opioid use 30–120 days post-LT and incident adverse events (eg, psychiatric, substance use, chronic pain, fractures/falls, digestive). Results: Among 1338 LTRs, 899 (67.2%) received outpatient opioid prescriptions >30 days post-LT, of whom 553 (41%) had incident use; 122 (13.6%) had high-risk opioid use. Factors significantly associated with high-risk use were female sex, pre-LT opioid use, and psychiatric disorder. Opioid use was significantly associated with increased adverse events 120–365 days post-LT; 59% of LTRs with opioid use within 1 year of LT developed complications compared to 39% of non-opioid users during this window (p<0.001). In adjusted landmark analyses, low/moderate opioid use within 30–120 days post-LT was associated with 1.87 times the hazard of complications compared to no opioid use at 120 days post-LT (95% CI: 1.14–3.07) and high-risk opioid use was associated with 2.87 (95% CI: 1.05–7.85) times the hazard. Conclusions: Post-LT opioid use is associated with increased risk of adverse events. Caution is needed in opioid prescribing beyond the perioperative period, particularly for those with preexisting psychiatric conditions.


  • Open Access

    SentHYMNent: An Interpretable and Sentiment-Driven Model for Algorithmic Melody Harmonization

    by Stephen Hahn, Jerry Yin, Rico Zhu, Weihan Xu, Yue Jiang, Simon Mak, Cynthia Rudin

    Music composition and analysis is an inherently creative task, involving a combination of heart and mind. However, the vast majority of algorithmic music models completely ignore the "heart" component of music, resulting in output that often lacks the rich emotional direction found in human-composed music. Models that try to incorporate musical sentiment rely on a "valence-arousal" model, which insufficiently characterizes emotion in two dimensions. Furthermore, existing methods typically adopt a black-box, music agnostic approach, treating music-theoretical and sentimental understanding as a by-product that can be inferred given sufficient data. In this study, we introduce two major novel elements: a nuanced mixture-based representation for musical sentiment, including a web tool to gather data, as well as a sentiment- and theory-driven harmonization model, SentHYMNent. SentHYMNent employs a novel Hidden Markov Model based on both key and chord transitions, as well as sentiment mixtures, to provide a probabilistic framework for learning key modulations and chordal progressions from a given melodic line and sentiment. Furthermore, our approach leverages compositional principles, resulting in a simpler model that significantly reduces computational burden and enhances interpretability compared to current state-of-the-art algorithmic harmonization methods. Importantly, as shown in our experiments, these improvements do not come at the expense of harmonization quality. We also provide a web app where users can upload their own melodies for SentHYMNent to harmonize.


  • Quantile regression in the field of liver transplantation: A case study–based tutorial

    by Yue Jiang, Sarah R. Lieber

    We present a tutorial on quantile regression, an underutilized yet valuable class of multivariable linear regression models that allows researchers to understand more fully the conditional distribution of response as compared to models based on conditional means. Quantile regression models are flexible, have attractive interpretations, and are implemented in most statistical software packages. Our focus is on an intuitive understanding of quantile regression models, particularly as compared with more familiar regression methods such as conditional mean models as estimated using ordinary least squares (OLS). We frame our tutorial through 2 clinical case studies in the field of liver transplantation: one in the context of estimating the recipient's financial burden after transplantation and another in estimating intraoperative blood transfusion needs. Our real-world cases demonstrate how quantile regression models give researchers a richer understanding of relationships in the data and provide a more nuanced clinical understanding compared to more commonly used linear regression models. We encourage researchers to explore quantile regression as a tool to answer relevant clinical research questions and support their more widespread adoption.

  • Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden

    by Sarah R. Lieber, Alex R. Jones, Yue Jiang, Prajwal Gowda, Madhukar Patel, Ben Lippe, Akhil Shenoy, Donna M. Evon, Tami Gurley, Van Ngo, et al.

    Psychiatric disorders after liver transplantation (LT) are associated with worse patient and graft outcomes, which may be amplified by inadequate treatment. We aimed to characterize the burden of psychiatric disorders, treatment patterns, and associated financial burden among liver transplantation recipients (LTRs). IQVIA PharMetrics (R) Plus for Academics—a large health plan claims database representative of the commercially insured US population—was used to identify psychiatric diagnoses among adult LTRs and assess treatment. Multivariable logistic regression analysis identified factors associated with post-LT psychiatric diagnoses and receipt of pharmacotherapy. Patient financial liability was estimated using adjudicated medical/pharmacy claims for LTRs with and without psychiatric diagnoses. Post-LT psychiatric diagnoses were identified in 395 (29.5%) of 1338 LTRs, of which 106 (26.8%) were incident cases. Treatment varied, with 67.3% receiving pharmacotherapy, 32.1% psychotherapy, 21.0% combination therapy, and 21.5% no treatment. Among 340 LTRs on psychotropic medications before transplant, 24% did not continue them post-LT. Post-LT psychiatric diagnoses were independently associated with female sex, alcohol-associated liver disease (ALD), prolonged LT hospitalization (>2 wk), and pre-LT psychiatric diagnosis. Incident psychiatric diagnoses were associated with female sex, ALD, and prolonged LT hospitalization. Patients with a post-LT psychiatric diagnosis had higher rates of hospitalization (89.6% vs. 81.5%, p$5K. Over 1 in 4 LTRs had a psychiatric diagnosis in a large national cohort, yet nearly a quarter received no treatment. LTRs with psychiatric diagnoses experienced increased health care utilization and higher financial liability. Sociodemographic and clinical risk factors could inform high-risk subgroups who may benefit from screening and mitigation strategies.


  • The financial burden after liver transplantation is significant among commercially insured adults: A large US National Cohort

    by Sarah R. Lieber, Yue Jiang, Alex R. Jones, Prajwal Gowda, Nneka N. Ufere, Madhukar S. Patel, Tami Gurley, Alvaro Noriega Ramirez, Van M. Ngo, Mary C. Olumesi, et al.

    Liver transplantation (LT) is lifesaving for patients with cirrhosis; however, the resultant financial burden to patients has not been well characterized. We aimed to provide a nationally representative portrayal of patient financial burden after LT. Adult recipients of LT from 2006 to 2021 were identified using IQVIA PharMetrics® Plus for Academics—a large nationally representative claims database of commercially insured Americans. Patient financial liability (ie, what patients owe) was estimated using the difference between allowed and paid costs for adjudicated medical/pharmacy claims. Descriptive statistics were provided stratified by the financial liability group within 1 year after LT. Multivariable logistic regression modeling identified factors associated with high/extreme liability adjusting for covariates. Potential indirect costs of post-LT care were estimated based on hourly wages lost for care. Among 1412 recipients of LT, financial liability was heterogeneous—~3% had no liability and 21% had extreme liability > $10K for 1-year post-LT care; most (69%) paid between $1 and 10K, with 48% having liability >$5K. Factors associated with >$5K liability included older age, insurance/enrollment type, US region, history of HCC, and simultaneous liver-kidney transplant (for liability >$10K). Medication costs comprised ~30% of outpatient financial liability. Potential indirect costs from wages lost were $2,201–$6,073 per person, depending on an hourly wage. In a large national cohort of commercially insured recipients of LT, financial liability was highly variable across sociodemographic and clinical characteristics; nearly 1 out of 2 recipients of LT owed >$5K for 1 year of post-LT care. Transplant programs should help patients anticipate potential costs and identify vulnerable populations who would benefit from enhanced financial counseling.


  • Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch

    by Maia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, Laura Raffals, Marla Dubinsky, Shannon Chang, Peter D.R. Higgins, Yue Jiang, Raymond K. Cross, Millie D. Long, et al.

    INTRODUCTION: There is a paucity of data on the real-world effectiveness of therapies in patients with Crohn's disease of the pouch. METHODS: This was a prospective multicenter study evaluating the primary outcome of remission at 12 months of therapy for Crohn's disease of the pouch. RESULTS: One hundred thirty-four patients were enrolled. Among the 77 patients with symptoms at baseline, 35 (46.7%) achieved remission at 12 months. Of them, 12 (34.3%) changed therapy. There was no significant association between therapy patterns and remission status. DISCUSSION: Approximately 50% with symptoms at enrollment achieved clinical remission at 12 months, most of whom did so without a change in therapy.


  • Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry

    by Rishika Chugh, Millie D. Long, Yue Jiang, Kimberly N. Weaver, Dawn B. Beaulieu, Ellen J. Scherl, Uma Mahadevan

    Background: Pregnancy outcomes in patients with inflammatory bowel disease with quiescent disease are similar to those in the general population. Data from the Pregnancy Inflammatory bowel disease And Neonatal Outcomes registry have demonstrated the safety of antitumor necrosis factor (TNF) α agents and thiopurines in pregnancy. The objective of this study was to provide information from the Pregnancy Inflammatory bowel disease And Neonatal Outcomes registry on maternal and fetal outcomes in patients exposed to the newer biologics ustekinumab (UST) and vedolizumab (VDZ). Methods: In this multicenter prospective observational study, we included pregnant women with singleton pregnancies and a diagnosis of inflammatory bowel disease. Questionnaires were administered to women at study intake, each subsequent trimester, delivery, and 4, 9, and 12 months after birth. Bivariate analyses were used to determine the independent effects of specific drug classes on outcomes. The exposure cohorts were VDZ, UST, anti-TNF, immunomodulators, and combination with anti-TNF and immunomodulators. All were compared with no exposure and with biologics/immunomodulators. Results: There were 1,669 completed pregnancies with 1,610 live births. The maternal mean age was 32.1 (SD 4.6) years at delivery with 66 VDZ exposed and 47 UST exposed. Women on UST were more likely to have Crohn's disease. There was no increased risk of spontaneous abortion, small for gestational age, low birth weight, neonatal intensive care unit stay, congenital malformations, or intrauterine growth restriction with in utero VDZ or UST exposure. The rate of preterm birth was lower (0.0%) for the UST-exposed cohort when compared with other cohorts including VDZ (13.8%), anti-TNF (8.2%), combination therapy (14.2%), immunomodulators (12.3%), and unexposed (9.7%) (P = 0.03). Rates of serious infections at birth, 4 months, and within the first 12 months of life were comparable among all cohorts. Nonserious infections were lower at 12 months in UST-exposed pregnancies. There was no increased risk signal for placental complications in the VDZ cohort. UST infant concentrations at birth were increased whereas VDZ concentrations were overall decreased compared with maternal serum drug concentration. DISCUSSION: This analysis of UST and VDZ exposure during pregnancy suggests no increase in complications compared with TNF, immunomodulators, and combination TNF/immunomodulators. No signal was found for increased placental events with either therapy. Continuation of UST and VDZ throughout pregnancy is recommended.


  • Open Access

    An Interpretable, Flexible, and Interactive Probabilistic Framework for Melody Generation

    by Stephen Hahn, Rico Zhu, Simon Mak, Cynthia Rudin, Yue Jiang

    The fast-growing demand for algorithmic music generation is found throughout entertainment, art, education, etc. Unfortunately, most recent models are practically impossible to interpret or musically fine-tune, as they use deep neural networks with thousands of parameters. We introduce an interpretable, flexible, and interactive model, SchenkComposer, for melody generation that empowers users to be creative in all aspects of the music generation pipeline and allows them to learn from the process. We divide the task of melody generation into steps based on the process that a human composer using music-theoretical domain knowledge might use. First, the model determines phrase structure based on form analysis and identifies an appropriate number of measures. Using concepts from Schenkerian analysis, the model then finds a fitting harmonic rhythm, middleground harmonic progression, foreground rhythm, and melody in a hierarchical, scaffolded approach using a probabilistic context-free grammar based on musical contours. By incorporating theories of musical form and harmonic structure, our model produces music with long-term structural coherence. In extensive human experiments, we find that music generated with our approach successfully passes a Turing test in human experiments while current state-of-the-art approaches fail, and we further demonstrate superior performance and preference for our melodies compared to existing melody generation methods. Additionally, we developed and deployed a public website for SchenkComposer, and conducted preliminary user surveys. Through analysis, we show the strong viability and enjoyability of SchenkComposer.